Eritrea vs South Korea: Previously treated cases tested for RR-/MDR-TB
Eritrea
100.0%
in 2024
South Korea
100.0%
in 2024
Eritrea rank
1st
South Korea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Eritrea
- South Korea
How they compare
Eritrea currently reports 100.0% against 100.0% in South Korea, a difference of 0.0%.
The two have swapped places 6 times across 11 shared years of data; in 2013 it was South Korea ahead.
Eritrea ranks 1st and South Korea ranks 1st of 180 countries.
Across the 2 decades both report, Eritrea averaged higher in 1 and South Korea in 1.
Head to head by decade
| Decade | Eritrea | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.4% | 62.8% | 6.5% | South Korea |
| 2020s | 100.0% | 92.0% | 8.0% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Eritrea or South Korea?
- Eritrea, at 100.0% against 100.0% in South Korea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Eritrea and South Korea?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and South Korea?
- 11 years are reported by both, from 2013 to 2024.
- How do Eritrea and South Korea rank globally for previously treated cases tested for rr-/mdr-tb?
- Eritrea ranks 1st and South Korea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.